These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26869319)

  • 21. Gene Therapy for Alzheimer and Parkinson Diseases.
    Saad JF; Saad FA
    Curr Gene Ther; 2023; 23(3):163-169. PubMed ID: 37114789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease is getting easier to spot.
    Dolgin E
    Nature; 2018 Jul; 559(7715):S10-S12. PubMed ID: 30046081
    [No Abstract]   [Full Text] [Related]  

  • 23. Protein transmission in neurodegenerative disease.
    Peng C; Trojanowski JQ; Lee VM
    Nat Rev Neurol; 2020 Apr; 16(4):199-212. PubMed ID: 32203399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transthyretin variants with improved inhibition of β-amyloid aggregation.
    Mangrolia P; Yang DT; Murphy RM
    Protein Eng Des Sel; 2016 Jun; 29(6):209-218. PubMed ID: 27099354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attack on amyloid.
    Kahle PJ; De Strooper B
    EMBO Rep; 2003 Aug; 4(8):747-51. PubMed ID: 12897797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
    Zetterberg H; Hammarström P
    J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
    [No Abstract]   [Full Text] [Related]  

  • 29. Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils.
    Sakalauskas A; Ziaunys M; Smirnovas V
    Sci Rep; 2020 Sep; 10(1):14466. PubMed ID: 32879381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection.
    Gozes I
    J Mol Neurosci; 2004; 24(3):333-6. PubMed ID: 15655257
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicine. Prion-like behavior of amyloid-beta.
    Kim J; Holtzman DM
    Science; 2010 Nov; 330(6006):918-9. PubMed ID: 21071652
    [No Abstract]   [Full Text] [Related]  

  • 33. Convection-enhanced delivery of M13 bacteriophage to the brain.
    Ksendzovsky A; Walbridge S; Saunders RC; Asthagiri AR; Heiss JD; Lonser RR
    J Neurosurg; 2012 Aug; 117(2):197-203. PubMed ID: 22606981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What's next for Alzheimer treatment?: while Aβ isn't out of the picture yet, several other therapeutic routes are being explored.
    Schwartz A
    Ann Neurol; 2013 Apr; 73(4):A7-9. PubMed ID: 24643982
    [No Abstract]   [Full Text] [Related]  

  • 36. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspective: prevention is better than cure.
    Gandy S
    Nature; 2011 Jul; 475(7355):S15. PubMed ID: 21760576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation of the M13 life cycle II: Investigation of the control mechanisms of M13 infection and establishment of the carrier state.
    Smeal SW; Schmitt MA; Pereira RR; Prasad A; Fisk JD
    Virology; 2017 Jan; 500():275-284. PubMed ID: 27569186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tauons and prions: infamous cousins?
    Novak P; Prcina M; Kontsekova E
    J Alzheimers Dis; 2011; 26(3):413-30. PubMed ID: 21694453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.